| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 03/28/2002 | WO2002024686A2 Farnesyl transferase inhibiting 6-heterocyclylmethyl quinoline and quinazoline derivatives |
| 03/28/2002 | WO2002024684A1 Quinoline derivatives as antibacterials |
| 03/28/2002 | WO2002024683A1 Farnesyl transferase inhibiting 6-[(substituted phenyl)methyl]-quinoline and quinazoline derivatives |
| 03/28/2002 | WO2002024682A1 Farnesyl transferase inhibiting quinoline and quinazoline derivatives as farnesyl transferase inhibitors |
| 03/28/2002 | WO2002024681A2 Pyrazine derivatives as modulators of tyrosine kinases |
| 03/28/2002 | WO2002024680A1 Imidazole derivatives as raf kinase inhibitors |
| 03/28/2002 | WO2002024679A1 PYRIDINE DERIVATIVES WITH IKB-KINASE (IKK-β) INHIBITING ACTIVITY |
| 03/28/2002 | WO2002024667A1 4-amino-quinazolines |
| 03/28/2002 | WO2002024666A2 4-amino-quinazolines |
| 03/28/2002 | WO2002024662A1 New benzimidazolone derivatives displaying affinity at the serotonin and dopamine receptors |
| 03/28/2002 | WO2002024661A2 New n, n'-disubstituted benzimidazolone derivatives with affinity at the serotonin and dopamine receptors |
| 03/28/2002 | WO2002024653A1 Compounds and methods for modulation of estrogen receptors |
| 03/28/2002 | WO2002024651A1 A process for producing 2-amino-4,6-disubstituted nicotinic acid ester analogs |
| 03/28/2002 | WO2002024650A2 Pyridinone and pyridinethione derivatives having hiv inhibiting properties |
| 03/28/2002 | WO2002024649A1 Substituted amino-aza-cycloalkanes useful against malaria |
| 03/28/2002 | WO2002024646A1 Delta1-pyrrolines used as pesticides |
| 03/28/2002 | WO2002024636A2 N-acylsulfonamide apoptosis promoters |
| 03/28/2002 | WO2001072735A3 Benzopyranes useful as tnf alpha inhibitors |
| 03/28/2002 | WO2001064676A3 INHIBITORS OF p38-α KINASE |
| 03/28/2002 | US20020037900 Hydroxamic acid derivatives |
| 03/28/2002 | US20020037889 Imidazolidin-2-one derivatives; inhibiting bone resorption, vascular restenosis, diabetic retinopathy, macular degeneration, angiogenesis, atherosclerosis, inflammation, arthritis, viral disease, cancer and metastatic tumor growth |
| 03/28/2002 | US20020037886 Muscarinic agonists |
| 03/28/2002 | US20020037852 Anticarcinogenic agents |
| 03/28/2002 | US20020037534 Combinatorial preparation of a substance library with removal of a zwitterionic compound by precipitation |
| 03/28/2002 | DE10040858A1 Perfluoralkylhaltige Komplexe mit polaren Resten, Verfahren zu deren Herstellung und ihre Verwendung Perfluoroalkyl-containing complexes with polar radicals, process for their preparation and their use |
| 03/28/2002 | CA2423315A1 Substituted amino-aza-cycloalkanes useful against malaria |
| 03/28/2002 | CA2423154A1 Imidazole derivatives as raf kinase inhibitors |
| 03/28/2002 | CA2423106A1 Compounds and methods for modulation of estrogen receptors |
| 03/28/2002 | CA2423050A1 Pyrazine derivatives as modulators of tyrosine kinases |
| 03/28/2002 | CA2422923A1 Pyridine derivatives with ikb-kinase (ikk-.beta.) inhibiting activity |
| 03/28/2002 | CA2422560A1 4-amino-quinazolines |
| 03/28/2002 | CA2422488A1 4-amino-quinazolines |
| 03/27/2002 | EP1189900A1 Heterocyclic aminopyrrolidine derivatives as melatonergic agents |
| 03/27/2002 | EP1189896A1 Substituted 5-oxo-5,6,7,8-tetrahydro-4h-1-benzopyrans and benzothiopyrans and the use thereof as potentiators of ampa |
| 03/27/2002 | EP1189893A2 Substituted 2-aryl-1,2,4-triazine-3,5-di(thi)one |
| 03/27/2002 | EP1189890A1 Dihydrobenzodiazepins and their use for treating dyslipidemia |
| 03/27/2002 | EP1189888A1 HETEROSUBSTITUTED PYRIDINE DERIVATIVES AS $i(PDE 4) INHIBITORS |
| 03/27/2002 | EP1189881A1 Propanoic acid derivatives that inhibit the binding of integrins to their receptors |
| 03/27/2002 | EP1189628A1 Combination of tumor necrosis factor (tnf) antagonists and cox-2 inhibitors for the treatment of inflammation |
| 03/27/2002 | EP1189609A1 Cxcr-4 receptor antagonists - thrombopoietin mimetics |
| 03/27/2002 | EP1189583A1 Indole derivatives |
| 03/27/2002 | EP0822931B1 Piperazinones useful as inhibitors of platelet aggregation |
| 03/27/2002 | EP0820287B1 Thrombin inhibitors |
| 03/27/2002 | EP0792153B1 Compositions containing lazaroids and their use for preventing adhesions |
| 03/27/2002 | EP0651746B1 Drugs that enhance synaptic responses mediated by ampa receptors |
| 03/27/2002 | CN1342157A Substituted pyrazoles ASP38 kinase inhibitors |
| 03/27/2002 | CN1342151A 喹啉和喹喔啉化合物 Quinoline and quinoxaline compounds |
| 03/27/2002 | CN1342150A Quinoline and quinoxaline compounds as PDGF-receptor and/or LCK tyrosine kinase inhibitors |
| 03/27/2002 | CN1342149A Prostaglandin endoperoxide H synthase biosynthesis inhibitors |
| 03/27/2002 | CN1342145A Fused-ring compounds and use thereof as drugs |
| 03/27/2002 | CN1342074A Antidepressant heterocyclic compounds |
| 03/27/2002 | CN1341594A Substituted pyrrolidone, thiazolidone or oxazolidone as herbicide |
| 03/27/2002 | CN1341593A Proteinase inhibitor |
| 03/27/2002 | CN1341592A Proteinase inhibitor |
| 03/27/2002 | CN1341590A Proteinase inhibitor |
| 03/27/2002 | CN1081635C Substituted pyrrolidine-3-Yl-alkyl-piperidines |
| 03/27/2002 | CN1081625C 1-aryl-2-acylamino-ethane compounds and their use as meurokinin especially neurokinin 1 antagonists |
| 03/26/2002 | US6362210 Carboxylic acid amides, pharmaceutical compositions containing these compounds and their use |
| 03/26/2002 | US6362201 3-cyclopropyl and 3-cyclobutyl pyrrolidine modulators of chemokine receptor activity |
| 03/26/2002 | US6362196 Method to treat pain utilizing benzimidazole NMDA/NR2B antagonists |
| 03/26/2002 | US6362177 Cyclic amine derivatives and their use as drugs |
| 03/26/2002 | CA2137953C Benzenesulfonamide derivative and process for preparing thereof |
| 03/21/2002 | WO2002022618A1 Method for preparing camptothecin and its derivatives |
| 03/21/2002 | WO2002022609A1 Process for producing paroxetine salt containing substantially no organic solvent |
| 03/21/2002 | WO2002022608A1 Pyrazole compounds useful as protein kinase inhibitors |
| 03/21/2002 | WO2002022607A1 Pyrazole compounds useful as protein kinase inhibitors |
| 03/21/2002 | WO2002022606A1 Pyrazole compounds useful as protein kinase inhibitors |
| 03/21/2002 | WO2002022605A1 Pyrazole compounds useful as protein kinase inhibitors |
| 03/21/2002 | WO2002022604A1 Pyrazole compounds useful as protein kinase inhibitors |
| 03/21/2002 | WO2002022603A1 Pyrazole compounds useful as protein kinase inhibitors |
| 03/21/2002 | WO2002022602A2 Triazole compounds useful as protein kinase inhibitors |
| 03/21/2002 | WO2002022601A1 Pyrazole compounds useful as protein kinase inhibitors |
| 03/21/2002 | WO2002022600A2 Chemokine receptor binding heterocyclic compounds |
| 03/21/2002 | WO2002022598A1 Quinolinone derivatives as tyrosine kinase inhibitors |
| 03/21/2002 | WO2002022577A2 Hydroxamate derivatives useful as deacetylase inhibitors |
| 03/21/2002 | WO2002022576A2 3-substituted indole carbohydrazides useful as cell proliferation and angiogenesis inhibitors |
| 03/21/2002 | WO2002022572A2 Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission) |
| 03/21/2002 | WO2002022556A1 Novel amide derivatives and medicinal use thereof ugs |
| 03/21/2002 | WO2001087846A3 Tricyclic pyrazole derivatives as protein kinase inhibitors |
| 03/21/2002 | WO2001055106A3 Novel melanocortin receptor agonists and antagonists |
| 03/21/2002 | US20020035147 Nervous system, psychological disorders |
| 03/21/2002 | US20020035136 Amino(oxo) acetic acid protein tyrosine phosphatase inhibitors |
| 03/21/2002 | US20020035132 Tetrahydropyran derivatives and their use as therapeutic agents |
| 03/21/2002 | US20020035131 Administering paroxetine |
| 03/21/2002 | US20020035130 Antidepressants, therapy for Parkinson's disease |
| 03/21/2002 | US20020035129 Cholinesterase inhibitor |
| 03/21/2002 | US20020035128 Cholinesterase inhibitors |
| 03/21/2002 | US20020035125 Therapeutic combination |
| 03/21/2002 | US20020035113 Piperidine, tetrahydropyridine and piperazine derivatives, their preparation and use |
| 03/21/2002 | US20020035104 Integrin receptor inhibitors |
| 03/21/2002 | US20020035103 For diseases or conditions caused by or exacerbated by histamine-3 receptor activity |
| 03/21/2002 | US20020035102 Azetidine derivatives, their preparation and medicaments containing them |
| 03/21/2002 | US20020035094 Substituted pyridine compounds and methods of use |
| 03/21/2002 | US20020035092 Propanoic acid derivatives |
| 03/21/2002 | US20020033453 Infrared imager using room temperature capacitance sensor |
| 03/21/2002 | DE10045530A1 Kombinatorische Herstellung einer Substanzbibliothek unter Abtrennung einer zwitterionischen Verbindung durch Fällung Combinatorial preparation of a compound library with removal of a zwitterionic compound by precipitation |
| 03/21/2002 | CA2422055A1 Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission) |
| 03/21/2002 | CA2419224A1 Chemokine receptor binding heterocyclic compounds |
| 03/20/2002 | EP1188755A1 Acylhydrazine derivatives, process for preparing the same and use thereof |
| 03/20/2002 | EP1188754A1 Substituted pyrazole compounds |